Power of Attorney for Donn Casale
2026-06-01SEC Filing 3 (0002135296-26-000005)
This filing documents a Power of Attorney granted by Donn Casale, President of ARS Pharmaceuticals, Inc., to Richard Lowenthal, Kathleen Scott, and Justin Chakma. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5 on behalf of Mr. Casale with the SEC and other authorities, as required by Section 16(a) of the Securities Exchange Act of 1934. This authorization remains in effect until Mr. Casale is no longer required to file these forms, he revokes it in writing, or the appointed attorneys-in-fact leave the company. The Power of Attorney was executed on May 12, 2026.
Ticker mentioned:SPRY
Source:Original SEC Document β